In addition, the result also found that HCV genotype 3 combined with the MTTP gene dominant model mutation results in an 11.57-fold increase in the risk of development of liver steatosis (OR = 11.57, 95% CIs: 4.467 -29.962, P < 0.001, Fig. 4). This evidence concerns the gene MT-TP and fatty liver disease.